A detailed history of Investment Management Associates Inc transactions in Pfizer Inc stock. As of the latest transaction made, Investment Management Associates Inc holds 18,273 shares of PFE stock, worth $517,125. This represents 0.18% of its overall portfolio holdings.

Number of Shares
18,273
Previous 19,869 8.03%
Holding current value
$517,125
Previous $551,000 7.26%
% of portfolio
0.18%
Previous 0.19%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

SELL
$25.26 - $29.6 $40,314 - $47,241
-1,596 Reduced 8.03%
18,273 $511,000
Q4 2023

Feb 09, 2024

SELL
$26.13 - $33.94 $177,396 - $230,418
-6,789 Reduced 25.47%
19,869 $572,000
Q3 2023

Nov 01, 2023

SELL
$32.09 - $37.51 $6,000 - $7,014
-187 Reduced 0.7%
26,658 $884,000
Q2 2023

Aug 01, 2023

BUY
$36.12 - $41.79 $15,242 - $17,635
422 Added 1.6%
26,845 $984,000
Q1 2023

May 02, 2023

BUY
$39.39 - $51.28 $14,337 - $18,665
364 Added 1.4%
26,423 $1.08 Million
Q4 2022

Feb 02, 2023

BUY
$41.75 - $54.5 $74,690 - $97,500
1,789 Added 7.37%
26,059 $1.34 Million
Q3 2022

Nov 01, 2022

SELL
$43.76 - $53.42 $18,335 - $22,382
-419 Reduced 1.7%
24,270 $1.06 Million
Q1 2022

May 02, 2022

SELL
$45.75 - $56.69 $41,449 - $51,361
-906 Reduced 3.54%
24,689 $1.28 Million
Q3 2021

Nov 02, 2021

BUY
$39.25 - $50.42 $9,263 - $11,899
236 Added 0.93%
25,595 $1.1 Million
Q2 2021

Jul 30, 2021

BUY
$35.91 - $40.68 $51,315 - $58,131
1,429 Added 5.97%
25,359 $993,000
Q1 2021

May 07, 2021

BUY
$33.49 - $37.77 $478,706 - $539,884
14,294 Added 148.34%
23,930 $867,000
Q4 2020

Mar 16, 2021

BUY
$33.47 - $42.56 $322,516 - $410,108
9,636 New
9,636 $355,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $159B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Investment Management Associates Inc Portfolio

Follow Investment Management Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment Management Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Investment Management Associates Inc with notifications on news.